| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $276M | — | $237M | — | 16.5% |
| Op. Income | $11M | — | $5M | — | 144.4% |
| Gross Margin | 74.4% | — | 72.6% | — | 1.9pp |
| Net Margin | 6.0% | — | 4.4% | — | 1.6pp |
| EPS (Diluted) | $0.32 | — | $0.20 | — | 60.0% |
| Free Cash Flow | $25M | — | -$6M | — | 525.9% |
| Item | Amount |
|---|---|
| REVENUE | $276M |
| Cost of Revenue | $71M |
| GROSS PROFIT | $206M |
| R&D Expenses | $28M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $167M |
| Other Expenses | $0 |
| Operating Expenses | $195M |
| Cost & Expenses | $265M |
| OPERATING INCOME | $11M |
| Interest Income | $7M |
| Interest Expense | $2M |
| Other Income/Expenses | $6M |
| INCOME BEFORE TAX | $17M |
| Income Tax Expense | $859.0K |
| Net Income from Continuing Ops | $17M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $17M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $17M |
| D&A | $11M |
| EBIT | $19M |
| EBITDA | $30M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $276M |
| Cost of Revenue | $71M |
| GROSS PROFIT | $206M |
| R&D Expenses | $28M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $167M |
| Other Expenses | $0 |
| Operating Expenses | $195M |
| Cost & Expenses | $265M |
| OPERATING INCOME | $11M |
| Interest Income | $7M |
| Interest Expense | $2M |
| Other Income/Expenses | $6M |
| INCOME BEFORE TAX | $17M |
| Income Tax Expense | $859.0K |
| Net Income from Continuing Ops | $17M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $17M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $17M |
| D&A | $11M |
| EBIT | $19M |
| EBITDA | $30M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $17M |
| Depreciation & Amortization | $11M |
| Stock-Based Compensation | $39M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $7M |
| Change in Working Capital | -$21M |
| OPERATING CASH FLOW | $52M |
| Capital Expenditure | -$27M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$72M |
| Sales/Maturities of Investments | $56M |
| Other Investing Activities | -$27M |
| NET CASH FROM INVESTING | -$44M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$7M |
| NET CASH FROM FINANCING | $7M |
| FREE CASH FLOW | $25M |
| Net Change in Cash | $15M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $100M |
| Short-Term Investments | $37M |
| Net Receivables | $85M |
| Inventory | $18M |
| Other Current Assets | $8M |
| TOTAL CURRENT ASSETS | $247M |
| PP&E (Net) | $173M |
| Goodwill | $0 |
| Intangible Assets | $6M |
| Long-Term Investments | $61M |
| Tax Assets | $0 |
| Other Non-Current Assets | $341.0K |
| TOTAL NON-CURRENT ASSETS | $241M |
| TOTAL ASSETS | $488M |
| Account Payables | $16M |
| Short-Term Debt | $14M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $19M |
| TOTAL CURRENT LIABILITIES | $49M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $84M |
| TOTAL LIABILITIES | $133M |
| Common Stock | $731M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | -$376M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $275.0K |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $355M |
| Minority Interest | $0 |
| TOTAL EQUITY | $355M |
| TOTAL LIABILITIES & EQUITY | $488M |
| Total Debt | $98M |
| Net Debt | -$2M |
